Intrinsic value of Horizon Therapeutics Public Limited Company (HZNP)

[per Chepakovich valuation model]

other valuations of HZNP

[per Chepakovich valuation model]  See other valuations of HZNP stock

Previous Close$101.05
Intrinsic Value
Upside potential
Previous Close
$101.05

VALUATION INPUT DATA

Revenue, mln $
Initial revenue growth rate (norm.), %
Variable cost ratio, %
Fixed operating expenses, mln $
Production assets / Revenue, %
Working capital / Revenue, %
Interest rate on debt, %
Life of production assets, yrs
Initial discount rate, %
Shares outstanding, mln
Adjusted equity ratio
Adjusted assets / Revenue
Based on fiscal year data as of 2020-12-31 and quarterly data as of 2021-03-31.
NOTE: The bar chart shows historic and forecasted yearly revenue growth rates. Its purpose is to help you in determining what initial revenue rate you want to base your stock valuation on. Please make sure that you are confident in the value you select - for most stocks it is by far the most important parameter in valuation.
  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2020(a)2021202220232024202520262027202820292030203120322033203420352036203720382039204020412042204320442045

INCOME STATEMENT

Revenue growth rate, %69.3NaN
Revenue, $2200NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m1710NaN
Operating income, $m490NaN
EBITDA, $m782NaN
Interest expense (income), $mNaN
Earnings before tax, $m402NaN
Tax expense, $m12NaN
Net income, $m390NaN

BALANCE SHEET

Cash and short-term investments, $m2083NaN
Total assets, $m6073NaN
Adjusted assets (=assets-cash), $m3989NaN
Average production assets, $m2266NaN
Working capital, $m2195NaN
Total debt, $m1003NaN
Total liabilities, $m2047NaN
Total equity, $m4025NaN
Debt-to-equity ratio0.249NaN
Adjusted equity ratio0.487NaN

CASH FLOW

Net income, $m390NaN
Depreciation, amort., depletion, $m292NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m556NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-164NaN
Free cash flow, $m720NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m2195
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN